Skip to main content

Wiskott-Aldrich syndrome as a model of cytoskeleton defects

  • Chapter
Lymphocyte Trafficking in Health and Disease

Part of the book series: Progress in Inflammation Research ((PIR))

  • 516 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Perry GS III, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR, Fahlstrom SM, Krivit W, Kersey JH (1980) The Wiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97: 72–78

    Article  PubMed  Google Scholar 

  2. Thrasher AJ, Kinnon C (2000) The Wiskott-Aldrich syndrome. Clin Exp Immunol 120: 2–9

    Article  PubMed  CAS  Google Scholar 

  3. Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM, Gout I (1996) Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol 6: 981–988

    Article  PubMed  CAS  Google Scholar 

  4. Stewart DM, Treiber-Held S, Kurman CC, Facchetti F, Notarangelo LD, Nelson DL (1996) Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest 97: 2627–2634

    PubMed  CAS  Google Scholar 

  5. Derry JM, Ochs HD, Francke U (1994) Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78: 635–644

    Article  PubMed  CAS  Google Scholar 

  6. Parolini O, Berardelli S, Riedl E, Bello-Fernandez C, Strobl H, Majdic O, Knapp W (1997) Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood 90: 70–75

    PubMed  CAS  Google Scholar 

  7. Miki H, Miura K, Takenawa T (1996) N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J 15: 5326–5335

    PubMed  Google Scholar 

  8. Miki H, Suetsugu S, Takenawa T (1998) WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J 17: 6932–6941

    Article  PubMed  CAS  Google Scholar 

  9. Welch MD, Mullins RD (2002) Cellular control of actin nucleation. Annu Rev Cell Dev Biol 18: 247–288

    Article  PubMed  CAS  Google Scholar 

  10. Thrasher AJ (2002) WASp in immune-system organization and function. Nat Rev Immunol 2: 635–646

    Article  PubMed  CAS  Google Scholar 

  11. Ochs HD, Notarangelo LD (2005) Structure and function of the Wiskott-Aldrich syndrome protein. Curr Opin Hematol 12: 284–291

    Article  PubMed  CAS  Google Scholar 

  12. Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK (2000) Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404: 151–158

    Article  PubMed  CAS  Google Scholar 

  13. Ho HY, Rohatgi R, Lebensohn AM, Le M, Li J, Gygi SP, Kirschner MW (2004) Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 118: 203–216

    Article  PubMed  CAS  Google Scholar 

  14. Hemsath L, Dvorsky R, Fiegen D, Carlier MF, Ahmadian MR (2005) An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins. Mol Cell 20: 313–324

    Article  PubMed  CAS  Google Scholar 

  15. Torres E, Rosen MK (2006) Protein tyrosine kinase and GTPase signals cooperate to phosphorylate and activate WASP/N-WASP. J Biol Chem 281: 3513–3520

    Article  PubMed  CAS  Google Scholar 

  16. Higgs HN, Pollard TD (2000) Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J Cell Biol 150: 1311–1320

    Article  PubMed  CAS  Google Scholar 

  17. Insall R (2001) PH domains in WASP-a bug in the system? Wiskott-Aldrich syndrome protein. Trends Cell Biol 9: 211–212

    Google Scholar 

  18. Badour K, Zhang J, Shi F, Leng Y, Collins M, Siminovitch KA (2004) Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J Exp Med 199: 99–112

    Article  PubMed  CAS  Google Scholar 

  19. Gross BS, Wilde JI, Quek L, Chapel H, Nelson DL, Watson SP (1999) Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI. Blood 94: 4166–4176

    PubMed  CAS  Google Scholar 

  20. Guinamard R, Aspenstrom P, Fougereau M, Chavrier P, Guillemot JC (1998) Tyrosine phosphorylation of the Wiskott-Aldrich syndrome protein by Lyn and Btk is regulated by CDC42. FEBS Lett 434: 431–436

    Article  PubMed  CAS  Google Scholar 

  21. Oda A, Ochs HD, Druker BJ, Ozaki K, Watanabe C, Handa M, Miyakawa Y, Ikeda Y (1998) Collagen induces tyrosine phosphorylation of Wiskott-Aldrich syndrome protein in human platelets. Blood 92: 1852–1858

    PubMed  CAS  Google Scholar 

  22. Baba Y, Nonoyama S, Matsushita M, Yamadori T, Hashimoto S, Imai K, Arai S, Kunikata T, Kurimoto M, Kurosaki T et al (1999) Involvement of Wiskott-Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood 93: 2003–2012

    PubMed  CAS  Google Scholar 

  23. Torres E, Rosen MK (2003) Contingent phosphorylation/dephosphorylation provides a mechanism of molecular memory in WASP. Mol Cell 11: 1215–1227

    Article  PubMed  CAS  Google Scholar 

  24. Cory GO, Garg R, Cramer R, Ridley AJ (2002) Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein. J Biol Chem 277: 45115–45121

    Article  PubMed  CAS  Google Scholar 

  25. Cory GO, Cramer R, Blanchoin L, Ridley AJ (2003) Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2/3 complex and enhances actin polymerization by WASP. Mol Cell 11: 1229–1239

    Article  PubMed  CAS  Google Scholar 

  26. Ramesh N, Anton IM, Hartwig JH, Geha RS (1997) WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci USA 94: 14671–14676

    Article  PubMed  CAS  Google Scholar 

  27. Volkman BF, Prehoda KE, Scott JA, Peterson FC, Lim WA (2002) Structure of the NWASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich syndrome. Cell 111: 565–576

    Article  PubMed  CAS  Google Scholar 

  28. Anton IM, Saville SP, Byrne MJ, Curcio C, Ramesh N, Hartwig JH, Geha RS (2003) WIP participates in actin reorganization and ruffle formation induced by PDGF. J Cell Sci 116: 2443–2451

    Article  PubMed  CAS  Google Scholar 

  29. Martinez-Quiles N, Rohatgi R, Anton IM, Medina M, Saville SP, Miki H, Yamaguchi H, Takenawa T, Hartwig JH, Geha RS et al (2001) WIP regulates N-WASP-mediated actin polymerization and filopodium formation. Nat Cell Biol 3: 484–491

    Article  PubMed  CAS  Google Scholar 

  30. Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, Geha RS (2002) Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell 10: 1269–1281

    Article  PubMed  CAS  Google Scholar 

  31. Gallego MD, de la Fuente MA, Anton IM, Snapper S, Fuhlbrigge R, Geha RS (2006) WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1{alpha}. Int Immunol 18: 221–232

    Article  PubMed  CAS  Google Scholar 

  32. Imai K, Nonoyama S, Ochs HD (2003) WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr Opin Allergy Clin Immunol 3: 427–436

    Article  PubMed  CAS  Google Scholar 

  33. Benesch S, Lommel S, Steffen A, Stradal TE, Scaplehorn N, Way M, Wehland J, Rottner K (2002) Phosphatidylinositol 4,5-biphosphate (PIP2)-induced vesicle movement depends on N-WASP and involves Nck, WIP, and Grb2. J Biol Chem 277: 37771–37776

    Article  PubMed  CAS  Google Scholar 

  34. Suetsugu S, Miki H, Yamaguchi H, Takenawa T (2001) Requirement of the basic region of N-WASP/WAVE2 for actin-based motility. Biochem Biophys Res Commun 282: 739–744

    Article  PubMed  CAS  Google Scholar 

  35. Yarar D, D’Alessio JA, Jeng RL, Welch MD (2002) Motility determinants in WASP family proteins. Mol Biol Cell 13: 4045–4059

    Article  PubMed  CAS  Google Scholar 

  36. Burns S, Thrasher AJ, Blundell MP, Machesky L, Jones GE (2001) Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 98: 1142–1149

    Article  PubMed  CAS  Google Scholar 

  37. Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ (2000) Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 95: 2943–2946

    PubMed  CAS  Google Scholar 

  38. Badour K, Zhang J, Shi F, McGavin MK, Rampersad V, Hardy LA, Field D, Siminovitch KA (2003) The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity 18: 141–154

    Article  PubMed  CAS  Google Scholar 

  39. Orange JS, Ramesh N, Remold-O’Donnell E, Sasahara Y, Koopman L, Byrne M, Bonilla FA, Rosen FS, Geha RS, Strominger JL (2002) Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci USA 99: 11351–11356

    Article  PubMed  CAS  Google Scholar 

  40. Prehoda KE, Scott JA, Dyche MR, Lim WA (2000) Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. Science 290: 801–806

    Article  PubMed  CAS  Google Scholar 

  41. Rohatgi R, Ho HY, Kirschner MW (2000) Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate. J Cell Biol 150: 1299–1310

    Article  PubMed  CAS  Google Scholar 

  42. Kessels MM, Qualmann B (2002) Syndapins integrate N-WASP in receptor-mediated endocytosis. EMBO J 21: 6083–6094

    Article  PubMed  CAS  Google Scholar 

  43. McGavin MK, Badour K, Hardy LA, Kubiseski TJ, Zhang J, Siminovitch KA (2001) The intersectin 2 adaptor links Wiskott Aldrich Syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med 194: 1777–1787

    Article  PubMed  CAS  Google Scholar 

  44. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125: 876–885

    Article  PubMed  CAS  Google Scholar 

  45. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, Yata J, Mizutani S, Ochs HD, Nonoyama S (2004) Clinical course of patients with WASP gene mutations. Blood 103: 456–464

    Article  PubMed  CAS  Google Scholar 

  46. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O’Donnell E (1993) T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol 151: 4383–4390

    PubMed  CAS  Google Scholar 

  47. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, de Saint BG, Delaunay J, Schwarz K, Casanova JL et al (2003) Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111: e622–e627

    Article  PubMed  Google Scholar 

  48. Burns S, Cory GO, Vainchenker W, Thrasher AJ (2004) Mechanisms of WASp-mediated hematologic and immunologic disease. Blood 104: 3454–3462

    Article  PubMed  CAS  Google Scholar 

  49. Shcherbina A, Candotti F, Rosen FS, Remold-O’Donnell E (2003) High incidence of lymphomas in a subgroup of Wiskott-Aldrich syndrome patients. Br J Haematol 121: 529–530

    Article  PubMed  Google Scholar 

  50. Conley ME, Saragoussi D, Notarangelo L, Etzioni A, Casanova JL (2003) An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 109: 272–277

    Article  PubMed  CAS  Google Scholar 

  51. Notarangelo LD, Notarangelo LD, Ochs HD (2005) WASP and the phenotypic range associated with deficiency. Curr Opin Allergy Clin Immunol 5: 485–490

    Article  PubMed  CAS  Google Scholar 

  52. Notarangelo LD, Mazza C, Giliani S, D’Aria C, Gandellini F, Ravelli C, Locatelli MG, Nelson DL, Ochs HD, Notarangelo LD (2002) Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood 99: 2268–2269

    Article  PubMed  CAS  Google Scholar 

  53. Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, Strina D, Patrosso MC, Ramenghi U, Sacco MG (1995) X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet 9: 414–417

    Article  PubMed  CAS  Google Scholar 

  54. Zhu Q, Zhang M, Blaese RM, Derry JM, Junker A, Francke U, Chen SH, Ochs HD (1995) The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 86: 3797–3804

    PubMed  CAS  Google Scholar 

  55. Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, Gandellini F, Stewart DM, Zhu Q, Nelson DL et al (2004) Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 104: 4010–4019

    Article  PubMed  CAS  Google Scholar 

  56. Lutskiy MI, Rosen FS, Remold-O’Donnell E (2005) Genotype-proteotype linkage in the Wiskott-Aldrich syndrome. J Immunol 175: 1329–1336

    PubMed  CAS  Google Scholar 

  57. Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van Den Oord JJ, Verhoef GE, Boogaerts MA, Fryns JP, You D et al (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 27: 313–317

    Article  PubMed  CAS  Google Scholar 

  58. Ancliff PJ, Blundell MP, Cory GO, Calle Y, Kempski H, Toscano M, Jones GE, Ridley AJ, Sinclair J, Worth A et al (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein resulting in congenital neutropoenia. Blood (in press)

    Google Scholar 

  59. Snapper SB, Rosen FS, Mizoguchi E, Cohen P, Khan W, Liu CH, Hagemann TL, Kwan SP, Ferrini R, Davidson L et al (1998) Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9: 81–91

    Article  PubMed  CAS  Google Scholar 

  60. Zhang J, Shehabeldin A, da Cruz LA, Butler J, Somani AK, McGavin M, Kozieradzki I, dos Santos AO, Nagy A, Grinstein S et al (1999) Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med 190: 1329–1342

    Article  PubMed  CAS  Google Scholar 

  61. Vicente-Manzanares M, Sanchez-Madrid F (2004) Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol 4: 110–122

    Article  PubMed  CAS  Google Scholar 

  62. Manes S, Gomez-Mouton C, Lacalle RA, Jimenez-Baranda S, Mira E, Martinez A (2005) Mastering time and space: immune cell polarization and chemotaxis. Semin Immunol 17: 77–86

    Article  PubMed  CAS  Google Scholar 

  63. Lanzavecchia A, Sallusto F (2001) The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13: 291–298

    Article  PubMed  CAS  Google Scholar 

  64. Randolph GJ, Angeli V, Swartz MA (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5: 617–628

    Article  PubMed  CAS  Google Scholar 

  65. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252

    Article  PubMed  CAS  Google Scholar 

  66. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301–314

    Article  PubMed  CAS  Google Scholar 

  67. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA (1998) Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282: 480–483

    Article  PubMed  CAS  Google Scholar 

  68. Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11: 753–761

    Article  PubMed  CAS  Google Scholar 

  69. Chomarat P, Banchereau J, Davoust J, Palucka AK (2000) IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1: 510–514

    Article  PubMed  CAS  Google Scholar 

  70. Becker S, Warren MK, Haskill S (1987) Colony-stimulating factor-induced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol 139: 3703–3709

    PubMed  CAS  Google Scholar 

  71. Badolato R, Sozzani S, Malacarne F, Bresciani S, Fiorini M, Borsatti A, Albertini A, Mantovani A, Ugazio AG, Notarangelo LD (1998) Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J Immunol 161: 1026–1033

    PubMed  CAS  Google Scholar 

  72. Altman LC, Snyderman R, Blaese RM (1974) Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome. J Clin Invest 54: 486–493

    Article  PubMed  CAS  Google Scholar 

  73. Binks M, Jones GE, Brickell PM, Kinnon C, Katz DR, Thrasher AJ (1998) Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur J Immunol 28: 3259–3267

    Article  PubMed  CAS  Google Scholar 

  74. Calle Y, Chou HC, Thrasher AJ, Jones GE (2004) Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells. J Pathol 204: 460–469

    Article  PubMed  CAS  Google Scholar 

  75. Linder S, Kopp P (2005) Podosomes at a glance. J Cell Sci 118: 2079–2082

    Article  PubMed  CAS  Google Scholar 

  76. Linder S, Nelson D, Weiss M, Aepfelbacher M (1999) Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc Natl Acad Sci USA 96: 9648–9653

    Article  PubMed  CAS  Google Scholar 

  77. Calle Y, Jones GE, Jagger C, Fuller K, Blundell MP, Chow J, Chambers T, Thrasher AJ (2004) WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 103: 3552–3561

    Article  PubMed  CAS  Google Scholar 

  78. Burns S, Hardy SJ, Buddle J, Yong KL, Jones GE, Thrasher AJ (2004) Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil Cytoskeleton 57: 118–132

    Article  PubMed  Google Scholar 

  79. Jones GE, Zicha D, Dunn GA, Blundell M, Thrasher A (2002) Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. Int J Biochem Cell Biol 34: 806–815

    Article  PubMed  CAS  Google Scholar 

  80. Zicha D, Allen WE, Brickell PM, Kinnon C, Dunn GA, Jones GE, Thrasher AJ (1998) Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol 101: 659–665

    Article  PubMed  CAS  Google Scholar 

  81. de Noronha S, Hardy S, Sinclair J, Blundell MP, Strid J, Schulz O, Zwirner J, Jones GE, Katz DR, Kinnon C et al (2005) Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein. Blood 105: 1590–1597

    Article  PubMed  CAS  Google Scholar 

  82. Snapper SB, Meelu P, Nguyen D, Stockton BM, Bozza P, Alt FW, Rosen FS, von Andrian UH, Klein C (2005) WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol 77: 993–998

    Article  PubMed  CAS  Google Scholar 

  83. Olivier A, Jeanson-Leh L, Bouma G, Compagno D, Blondeau J, Seye K, Charrier S, Burns S, Thrasher AJ, Danos O et al (2006) A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells. Mol Ther 13(4): 729–737

    Article  PubMed  CAS  Google Scholar 

  84. Charrier S, Stockholm D, Seye K, Opolon P, Taveau M, Gross DA, Bucher-Laurent S, Delenda C, Vainchenker W, Danos O et al (2005) A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice. Gene Ther 12: 597–606

    Article  PubMed  CAS  Google Scholar 

  85. Allavena P, Badolato R, Facchetti F, Vermi W, Paganin C, Luini W, Giliani S, Mazza C, Bolzern U, Chiesa I et al (2001) Monocytes from Wiskott-Aldrich patients differentiate in functional mature dendritic cells with a defect in CD83 expression. Eur J Immunol 31: 3413–3421

    Article  PubMed  CAS  Google Scholar 

  86. Westerberg L, Wallin RP, Greicius G, Ljunggren HG, Severinson E (2003) Efficient antigen presentation of soluble, but not particulate, antigen in the absence of Wiskott-Aldrich syndrome protein. Immunology 109: 384–391

    Article  PubMed  CAS  Google Scholar 

  87. Leverrier Y, Lorenzi R, Blundell MP, Brickell P, Kinnon C, Ridley AJ, Thrasher AJ (2001) Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J Immunol 166: 4831–4834

    PubMed  CAS  Google Scholar 

  88. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ (1980) The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 55: 243–252

    PubMed  CAS  Google Scholar 

  89. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A (1998) Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82–86

    Article  PubMed  CAS  Google Scholar 

  90. Harder T (2004) Lipid raft domains and protein networks in T-cell receptor signal transduction. Curr Opin Immunol 16: 353–359

    Article  PubMed  CAS  Google Scholar 

  91. Cannon JL, Burkhardt JK (2004) Differential roles for Wiskott-Aldrich syndrome protein in immune synapse formation and IL-2 production. J Immunol 173: 1658–1662

    PubMed  CAS  Google Scholar 

  92. Gallego MD, Santamaria M, Pena J, Molina IJ (1997) Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90: 3089–3097

    PubMed  CAS  Google Scholar 

  93. Dupre L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C, Roncarolo MG (2002) Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17: 157–166

    Article  PubMed  CAS  Google Scholar 

  94. Molina IJ, Kenney DM, Rosen FS, Remold-O’Donnell E (1992) T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 176: 867–874

    Article  PubMed  CAS  Google Scholar 

  95. Gerwin N, Friedrich C, Perez-Atayde A, Rosen FS, Gutierrez-Ramos JC (1996) Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott-Aldrich syndrome. Clin Exp Immunol 106: 208–217

    Article  PubMed  CAS  Google Scholar 

  96. Vermi W, Blanzuoli L, Kraus MD, Grigolato P, Donato F, Loffredo G, Marino CE, Alberti D, Notarangelo LD, Facchetti F (1999) The spleen in the Wiskott-Aldrich syndrome: histopathologic abnormalities of the white pulp correlate with the clinical phenotype of the disease. Am J Surg Pathol 23: 182–191

    Article  PubMed  CAS  Google Scholar 

  97. Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O’Donnell E (2004) Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol 136: 104–110

    Article  PubMed  CAS  Google Scholar 

  98. Strom TS, Turner SJ, Andreansky S, Liu H, Doherty PC, Srivastava DK, Cunningham JM, Nienhuis AW (2003) Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood 102: 3108–3116

    Article  PubMed  CAS  Google Scholar 

  99. Klein C, Nguyen D, Liu CH, Mizoguchi A, Bhan AK, Miki H, Takenawa T, Rosen FS, Alt FW, Mulligan RC et al (2003) Gene therapy for Wiskott-Aldrich syndrome: rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101: 2159–2166

    Article  PubMed  CAS  Google Scholar 

  100. Dupre L, Trifari S, Follenzi A, Marangoni F, Laind L, Bernad A, Martino S, Tsuchiya S, Bordignon C, Naldini L et al (2004) Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther 10: 903–915

    Article  PubMed  CAS  Google Scholar 

  101. Strom TS, Gabbard W, Kelly PF, Cunningham JM, Nienhuis AW (2003) Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther 10: 803–809

    Article  PubMed  CAS  Google Scholar 

  102. Wada T, Jagadeesh GJ, Nelson DL, Candotti F (2002) Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T-cell dysfunction. Hum Gene Ther 13: 1039–1046

    Article  PubMed  CAS  Google Scholar 

  103. Park JY, Shcherbina A, Rosen FS, Prodeus AP, Remold-O’Donnell E (2005) Phenotypic perturbation of B cells in the Wiskott-Aldrich syndrome. Clin Exp Immunol 139: 297–305

    Article  PubMed  CAS  Google Scholar 

  104. Facchetti F, Blanzuoli L, Vermi W, Notarangelo LD, Giliani S, Fiorini M, Fasth A, Stewart DM, Nelson DL (1998) Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome. J Pathol 185: 99–107

    Article  PubMed  CAS  Google Scholar 

  105. Westerberg L, Greicius G, Snapper SB, Aspenstrom P, Severinson E (2001) Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes. Blood 98: 1086–1094

    Article  PubMed  CAS  Google Scholar 

  106. Candotti F, Facchetti F, Blanzuoli L, Stewart DM, Nelson DL, Blaese RM (1999) Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying ‘null’ mutations. Gene Ther 6: 1170–1174

    Article  PubMed  CAS  Google Scholar 

  107. Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E (2005) Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood 105: 1144–1152

    Article  PubMed  CAS  Google Scholar 

  108. Andreansky S, Liu H, Turner S, McCullers JA, Lang R, Rutschman R, Doherty PC, Murray PJ, Nienhuis AW, Strom TS (2005) WASP-mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp Hematol 33: 443–451

    Article  PubMed  CAS  Google Scholar 

  109. Henriquez NV, Rijkers GT, Zegers BJ (1994) Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome. J Immunol 153: 395–399

    PubMed  CAS  Google Scholar 

  110. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406: 309–314

    Article  PubMed  CAS  Google Scholar 

  111. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, Lipp M (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23–33

    Article  PubMed  CAS  Google Scholar 

  112. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, Nakano H (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189: 451–460

    Article  PubMed  CAS  Google Scholar 

  113. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A (1998) Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28: 2760–2769

    Article  PubMed  CAS  Google Scholar 

  114. Sozzani S, Allavena P, D’Amico G, Luini W, Bianchi G, Kataura M, Imai T, Yoshie O, Bonecchi R, Mantovani A (1998) Cutting edge: Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161: 1083–1086

    PubMed  CAS  Google Scholar 

  115. Lutz MB, Schuler G (2002) Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23: 445-449

    Google Scholar 

  116. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21: 685–711

    Article  PubMed  CAS  Google Scholar 

  117. O’Garra A, Vieira P (2004) Regulatory T cells and mechanisms of immune system control. Nat Med 10: 801–805

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Birkhäuser Verlag Basel/Switzerland

About this chapter

Cite this chapter

Bouma, G., Thrasher, A.J., Burns, S. (2006). Wiskott-Aldrich syndrome as a model of cytoskeleton defects. In: Badolato, R., Sozzani, S. (eds) Lymphocyte Trafficking in Health and Disease. Progress in Inflammation Research. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7442-X_13

Download citation

Publish with us

Policies and ethics